3897 |
Left Main Stent Technique and Decision Making: What We Have Learned from the DELTA Registry |
Alaide Chieffo |
Apr. 21. 16 |
3896 |
Scaffolds in Complex LM Lesions |
Marie-Claude Morice |
Apr. 21. 16 |
3895 |
Left Main PCI in Acute MI |
Michael S. Lee |
Apr. 21. 16 |
3894 |
Intervention of LMCA Bifurcation: Is It Different in 2016? |
Debabrata Dash |
Apr. 21. 16 |
3893 |
Extremely High Risk for TAVR - Insights from QOL and Cost-Effectiveness Studies |
David Joel Cohen |
Apr. 21. 16 |
3892 |
TAVR for Bicuspid AS |
Sung Han Yoon |
Apr. 21. 16 |
3891 |
Valve Thrombosis/Leaflet Thickening: To Treat or Not to Treat |
Raj Makkar |
Apr. 21. 16 |
3890 |
Paravalvular Regurgitation After TAVR: Insights from PARTNER II S3HR and S3i |
Susheel Kodali |
Apr. 21. 16 |
3889 |
Inferior Role of OMT Versus PCI |
Richard R. Heuser |
Apr. 21. 16 |
3888 |
Comparable Impact of OMT After Failed Versus Successful CTO-PCI |
Seung-Whan Lee |
Apr. 21. 16 |